1 Study Coverage 1.1 Osteoporosis Therapeutics Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Osteoporosis Therapeutics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Osteoporosis Therapeutics Market Size for the Year 2017-2028 1.2.2 Global Osteoporosis Therapeutics Market Size for the Year 2017-2028 1.3 Osteoporosis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Osteoporosis Therapeutics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Osteoporosis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Osteoporosis Therapeutics Market Dynamics 1.4.1 Osteoporosis Therapeutics Industry Trends 1.4.2 Osteoporosis Therapeutics Market Drivers 1.4.3 Osteoporosis Therapeutics Market Challenges 1.4.4 Osteoporosis Therapeutics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Osteoporosis Therapeutics by Type 2.1 Osteoporosis Therapeutics Market Segment by Type 2.1.1 Bisphosphonates 2.1.2 Hormones 2.1.3 Strontium Ranelate 2.1.4 Raloxifene 2.1.5 Denosumab 2.1.6 Others 2.2 Global Osteoporosis Therapeutics Market Size by Type (2017, 2022 & 2028) 2.3 Global Osteoporosis Therapeutics Market Size by Type (2017-2028) 2.4 United States Osteoporosis Therapeutics Market Size by Type (2017, 2022 & 2028) 2.5 United States Osteoporosis Therapeutics Market Size by Type (2017-2028) 3 Osteoporosis Therapeutics by Distribution Channel 3.1 Osteoporosis Therapeutics Market Segment by Distribution Channel 3.1.1 Hospital Pharmacies 3.1.2 Online Pharmacies 3.1.3 Retail Pharmacies 3.2 Global Osteoporosis Therapeutics Market Size by Distribution Channel (2017, 2022 & 2028) 3.3 Global Osteoporosis Therapeutics Market Size by Distribution Channel (2017-2028) 3.4 United States Osteoporosis Therapeutics Market Size by Distribution Channel (2017, 2022 & 2028) 3.5 United States Osteoporosis Therapeutics Market Size by Distribution Channel (2017-2028) 4 Global Osteoporosis Therapeutics Competitor Landscape by Company 4.1 Global Osteoporosis Therapeutics Market Size by Company 4.1.1 Top Global Osteoporosis Therapeutics Companies Ranked by Revenue (2021) 4.1.2 Global Osteoporosis Therapeutics Revenue by Player (2017-2022) 4.2 Global Osteoporosis Therapeutics Concentration Ratio (CR) 4.2.1 Osteoporosis Therapeutics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Osteoporosis Therapeutics in 2021 4.2.3 Global Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Osteoporosis Therapeutics Headquarters, Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Osteoporosis Therapeutics Headquarters and Area Served 4.3.2 Global Osteoporosis Therapeutics Companies Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Osteoporosis Therapeutics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Osteoporosis Therapeutics Market Size by Company 4.5.1 Top Osteoporosis Therapeutics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Osteoporosis Therapeutics Revenue by Players (2020, 2021 & 2022) 5 Global Osteoporosis Therapeutics Market Size by Region 5.1 Global Osteoporosis Therapeutics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Osteoporosis Therapeutics Market Size by Region (2017-2028) 5.2.1 Global Osteoporosis Therapeutics Market Size by Region: 2017-2022 5.2.2 Global Osteoporosis Therapeutics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Osteoporosis Therapeutics Market Size YoY Growth 2017-2028 6.1.2 North America Osteoporosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Osteoporosis Therapeutics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Osteoporosis Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Osteoporosis Therapeutics Market Size YoY Growth 2017-2028 6.3.2 Europe Osteoporosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Osteoporosis Therapeutics Market Size YoY Growth 2017-2028 6.4.2 Latin America Osteoporosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Osteoporosis Therapeutics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Osteoporosis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Warner Chilcott 7.1.1 Warner Chilcott Company Details 7.1.2 Warner Chilcott Business Overview 7.1.3 Warner Chilcott Osteoporosis Therapeutics Introduction 7.1.4 Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.1.5 Warner Chilcott Recent Development 7.2 Merck & Co. 7.2.1 Merck & Co. Company Details 7.2.2 Merck & Co. Business Overview 7.2.3 Merck & Co. Osteoporosis Therapeutics Introduction 7.2.4 Merck & Co. Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.2.5 Merck & Co. Recent Development 7.3 Roche 7.3.1 Roche Company Details 7.3.2 Roche Business Overview 7.3.3 Roche Osteoporosis Therapeutics Introduction 7.3.4 Roche Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.3.5 Roche Recent Development 7.4 Novartis 7.4.1 Novartis Company Details 7.4.2 Novartis Business Overview 7.4.3 Novartis Osteoporosis Therapeutics Introduction 7.4.4 Novartis Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.4.5 Novartis Recent Development 7.5 Ono 7.5.1 Ono Company Details 7.5.2 Ono Business Overview 7.5.3 Ono Osteoporosis Therapeutics Introduction 7.5.4 Ono Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.5.5 Ono Recent Development 7.6 Astellas Pharma 7.6.1 Astellas Pharma Company Details 7.6.2 Astellas Pharma Business Overview 7.6.3 Astellas Pharma Osteoporosis Therapeutics Introduction 7.6.4 Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.6.5 Astellas Pharma Recent Development 7.7 Procter & Gamble 7.7.1 Procter & Gamble Company Details 7.7.2 Procter & Gamble Business Overview 7.7.3 Procter & Gamble Osteoporosis Therapeutics Introduction 7.7.4 Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.7.5 Procter & Gamble Recent Development 7.8 Sumitomo Pharmaceuticals 7.8.1 Sumitomo Pharmaceuticals Company Details 7.8.2 Sumitomo Pharmaceuticals Business Overview 7.8.3 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Introduction 7.8.4 Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.8.5 Sumitomo Pharmaceuticals Recent Development 7.9 Servier 7.9.1 Servier Company Details 7.9.2 Servier Business Overview 7.9.3 Servier Osteoporosis Therapeutics Introduction 7.9.4 Servier Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.9.5 Servier Recent Development 7.10 Eli Lilly 7.10.1 Eli Lilly Company Details 7.10.2 Eli Lilly Business Overview 7.10.3 Eli Lilly Osteoporosis Therapeutics Introduction 7.10.4 Eli Lilly Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.10.5 Eli Lilly Recent Development 7.11 Pfizer 7.11.1 Pfizer Company Details 7.11.2 Pfizer Business Overview 7.11.3 Pfizer Osteoporosis Therapeutics Introduction 7.11.4 Pfizer Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.11.5 Pfizer Recent Development 7.12 Amgen 7.12.1 Amgen Company Details 7.12.2 Amgen Business Overview 7.12.3 Amgen Osteoporosis Therapeutics Introduction 7.12.4 Amgen Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.12.5 Amgen Recent Development 7.13 Chugai 7.13.1 Chugai Company Details 7.13.2 Chugai Business Overview 7.13.3 Chugai Osteoporosis Therapeutics Introduction 7.13.4 Chugai Revenue in Osteoporosis Therapeutics Business (2017-2022) 7.13.5 Chugai Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Osteoporosis Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Osteoporosis Therapeutics Market Trends Table 3. Osteoporosis Therapeutics Market Drivers Table 4. Osteoporosis Therapeutics Market Challenges Table 5. Osteoporosis Therapeutics Market Restraints Table 6. Global Osteoporosis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Osteoporosis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Osteoporosis Therapeutics Market Size by Distribution Channel: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Osteoporosis Therapeutics Market Size by Distribution Channel: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Osteoporosis Therapeutics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Osteoporosis Therapeutics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Osteoporosis Therapeutics Revenue Share by Player, 2017-2022 Table 13. Global Osteoporosis Therapeutics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Osteoporosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoporosis Therapeutics as of 2021) Table 15. Top Players of Osteoporosis Therapeutics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Osteoporosis Therapeutics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Osteoporosis Therapeutics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Osteoporosis Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Osteoporosis Therapeutics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Osteoporosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Osteoporosis Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Osteoporosis Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Osteoporosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Osteoporosis Therapeutics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Osteoporosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Osteoporosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Osteoporosis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Warner Chilcott Company Details Table 31. Warner Chilcott Business Overview Table 32. Warner Chilcott Osteoporosis Therapeutics Product Table 33. Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 34. Warner Chilcott Recent Development Table 35. Merck & Co. Company Details Table 36. Merck & Co. Business Overview Table 37. Merck & Co. Osteoporosis Therapeutics Product Table 38. Merck & Co. Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 39. Merck & Co. Recent Development Table 40. Roche Company Details Table 41. Roche Business Overview Table 42. Roche Osteoporosis Therapeutics Product Table 43. Roche Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 44. Roche Recent Development Table 45. Novartis Company Details Table 46. Novartis Business Overview Table 47. Novartis Osteoporosis Therapeutics Product Table 48. Novartis Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 49. Novartis Recent Development Table 50. Ono Company Details Table 51. Ono Business Overview Table 52. Ono Osteoporosis Therapeutics Product Table 53. Ono Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 54. Ono Recent Development Table 55. Astellas Pharma Company Details Table 56. Astellas Pharma Business Overview Table 57. Astellas Pharma Osteoporosis Therapeutics Product Table 58. Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 59. Astellas Pharma Recent Development Table 60. Procter & Gamble Company Details Table 61. Procter & Gamble Business Overview Table 62. Procter & Gamble Osteoporosis Therapeutics Product Table 63. Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 64. Procter & Gamble Recent Development Table 65. Sumitomo Pharmaceuticals Company Details Table 66. Sumitomo Pharmaceuticals Business Overview Table 67. Sumitomo Pharmaceuticals Osteoporosis Therapeutics Product Table 68. Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 69. Sumitomo Pharmaceuticals Recent Development Table 70. Servier Company Details Table 71. Servier Business Overview Table 72. Servier Osteoporosis Therapeutics Product Table 73. Servier Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 74. Servier Recent Development Table 75. Eli Lilly Company Details Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Osteoporosis Therapeutics Product Table 78. Eli Lilly Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 79. Eli Lilly Recent Development Table 80. Pfizer Company Details Table 81. Pfizer Business Overview Table 82. Pfizer Osteoporosis Therapeutics Product Table 83. Pfizer Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 84. Pfizer Recent Development Table 85. Amgen Company Details Table 86. Amgen Business Overview Table 87. Amgen Osteoporosis Therapeutics Product Table 88. Amgen Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 89. Amgen Recent Development Table 90. Chugai Company Details Table 91. Chugai Business Overview Table 92. Chugai Osteoporosis Therapeutics Product Table 93. Chugai Revenue in Osteoporosis Therapeutics Business (2017-2022) & (US$ Million) Table 94. Chugai Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Osteoporosis Therapeutics Product Picture Figure 2. Global Osteoporosis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Osteoporosis Therapeutics Market Size 2017-2028 (US$ Million) Figure 4. United States Osteoporosis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Osteoporosis Therapeutics Market Size 2017-2028 (US$ Million) Figure 6. United States Osteoporosis Therapeutics Market Share in Global 2017-2028 Figure 7. Osteoporosis Therapeutics Report Years Considered Figure 8. Product Picture of Bisphosphonates Figure 9. Product Picture of Hormones Figure 10. Product Picture of Strontium Ranelate Figure 11. Product Picture of Raloxifene Figure 12. Product Picture of Denosumab Figure 13. Product Picture of Others Figure 14. Global Osteoporosis Therapeutics Market Share by Type in 2022 & 2028 Figure 15. Global Osteoporosis Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 16. Global Osteoporosis Therapeutics Market Share by Type (2017-2028) Figure 17. United States Osteoporosis Therapeutics Market Share by Type in 2022 & 2028 Figure 18. United States Osteoporosis Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 19. United States Osteoporosis Therapeutics Market Share by Type (2017-2028) Figure 20. Product Picture of Hospital Pharmacies Figure 21. Product Picture of Online Pharmacies Figure 22. Product Picture of Retail Pharmacies Figure 23. Global Osteoporosis Therapeutics Market Share by Distribution Channel in 2022 & 2028 Figure 24. Global Osteoporosis Therapeutics Market Size by Distribution Channel (2017-2028) & (US$ Million) Figure 25. Global Osteoporosis Therapeutics Market Share by Distribution Channel (2017-2028) Figure 26. United States Osteoporosis Therapeutics Market Share by Distribution Channel in 2022 & 2028 Figure 27. United States Osteoporosis Therapeutics Market Size by Distribution Channel (2017-2028) & (US$ Million) Figure 28. United States Osteoporosis Therapeutics Market Share by Distribution Channel (2017-2028) Figure 29. North America Osteoporosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. U.S. Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Canada Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Europe Osteoporosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 33. Germany Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. France Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. U.K. Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Italy Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Russia Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Asia-Pacific Osteoporosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 39. China Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Japan Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. South Korea Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. India Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Australia Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Taiwan Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Indonesia Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Thailand Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Malaysia Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Philippines Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Latin America Osteoporosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Mexico Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Brazil Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Argentina Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Osteoporosis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 54. Turkey Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. U.A.E Osteoporosis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Warner Chilcott Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 58. Merck & Co. Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 59. Roche Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 60. Novartis Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 61. Ono Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 62. Astellas Pharma Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 63. Procter & Gamble Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 64. Sumitomo Pharmaceuticals Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 65. Servier Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 66. Eli Lilly Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 67. Pfizer Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 68. Amgen Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 69. Chugai Revenue Growth Rate in Osteoporosis Therapeutics Business (2017-2022) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Warner Chilcott Merck & Co. Roche Novartis Ono Astellas Pharma Procter & Gamble Sumitomo Pharmaceuticals Servier Eli Lilly Pfizer Amgen Chugai